Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease | Zendy

Esteban C. Gabazza | Zendy; Osamu Hataji | Zendy; Masahiro Naito | Zendy; Kentaro Ito | Zendy; Fumiaki Watanabe | Zendy; Osamu Taguchi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

Author(s) -

Esteban C. Gabazza,

Osamu Hataji,

Masahiro Naito,

Kentaro Ito,

Fumiaki Watanabe,

Osamu Taguchi

Publication year - 2012

Publication title -

international journal of copd

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 67

eISSN - 1178-2005

pISSN - 1176-9106

DOI - 10.2147/copd.s38548

Subject(s) - indacaterol , medicine , pulmonary disease , copd , intensive care medicine , physical therapy , asthma , bronchodilator

The current mainstay of therapy for chronic obstructive pulmonary disease (COPD) is long-acting bronchodilators. To date, the effect of indacaterol, a β2-agonist, on activities of daily living in COPD patients is not well understood. The aim of this study was to evaluate the efficacy of indacaterol with regard to activities of daily living in patients with COPD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research